12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

AutoloGel System regulatory update

Cytomedix said the Centers for Medicare & Medicaid Services (CMS) proposed guidelines covering Medicare reimbursement for its AutoloGel System, which isolates and activates platelet-rich plasma (PRP) from a patient's own blood and is then used to produce a gel for use on exuding...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >